Matthew J. Maletta is the Chief Legal Officer of Viatris, joining the Company in February 2026.
Matt is an accomplished public company executive, with nearly 30 years of legal experience and deep expertise in leading legal teams for both generic and branded pharmaceutical companies. From 2015 to 2025, he served as Executive Vice President, Chief Legal Officer and Corporate Secretary at Endo, where he oversaw Endo’s merger with Mallinckrodt and the subsequent spin-off of Par Health.
Prior to that, he served for over a decade in the legal department at Allergan, rising to Vice President, Associate General Counsel and Corporate Secretary. His experience at Allergan included serving as lead attorney for all business development transactions, including the $70 billion sale of Allergan to Actavis. He also served as a member of the Allergan Medical Management Team. During his early career, Matt was an Associate Attorney at Skadden, Arps, Slate, Meagher and Flom LLP.
Matt earned both his Bachelor of Arts degree in political science and his Juris Doctor degree from the University of Minnesota.